Lack of Access to Targeted Cancer Treatment Modalities in the Developing World in the Era of Precision Medicine: Real-Life Lessons From Bosnia
Patients with cancer in developing and low-income countries have limited access to targeted cancer therapies. The transitional nature of these economieshas influencedhealthcare funding,whichhas resulted in the unavailability of targeted cancer treatments. Besides the three studies that will be described here, to our knowledge, no literature exists on the clinical outcome of patients treated with delayed targeted cancer therapy. To raise awareness on the importance of timely targeted cancer treatment, we will discuss three key issues: (1) the low number of targeted cancer therapies for different cancers, (2) thedelay incancer treatment, and (3) the unavailability of cancer diagnostics.